Insider Profile
Sagan, Paul
1
Companies Filed At
1
Open-Market Buys (2yr)
$249K
Buy Value (2yr, open-market)
Mar 16, 2026
Most Recent Trade
0
Credibility
Score
0%
Hit Rate
-16.6%
Avg 90d Return
-16.6%
Median 90d Return
2
Evaluated Trades
-9.8%
Best Trade
-23.4%
Worst Trade
Hit rate and returns are based on 2 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
Hit Rate · 90d
-22.0%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Mar 16, 2026 $TRI
Thomson Reuters Corp
Other Buy 649 58
Mar 11, 2026 $TRI
Thomson Reuters Corp
Open Market Buy 2,360 $105.51 $249K 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 6 58
Dec 31, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 2 $128.65 $257 58
Dec 15, 2025 $TRI
Thomson Reuters Corp
Other Buy 478 $130.70 $62K 58
Sep 15, 2025 $TRI
Thomson Reuters Corp
Other Buy 361 $172.99 $62K 58
Jun 16, 2025 $TRI
Thomson Reuters Corp
Other Buy 100 $195.20 $20K 58
Jun 04, 2025 $TRI
Thomson Reuters Corp
Other Sell 58
Jun 04, 2025 $TRI
Thomson Reuters Corp
Other Sell 58
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.